Keywords: Fast generic approval, Consumer benefits, Rotman School of Management, Approval times

Speedy generic approval may not benefit consumers as much as expected, Rotman model shows

Article | 09 February 2011

Although faster approval times for generic drugs will get them into consumers' hands quicker, this may not make the price ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in